These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7374878)

  • 41. Effect of continuous ambulatory peritoneal dialysis on anemia in uremic patients.
    Marcovici O; Boner G; Rosenfeld JB
    Isr J Med Sci; 1983 Jul; 19(7):604-7. PubMed ID: 6885343
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Application of an erythrocyte aluminum assay in the diagnosis of aluminum-associated microcytic anemia in patients undergoing dialysis and response to deferoxamine therapy.
    Abreo K; Brown ST; Sella M; Trapp G
    J Lab Clin Med; 1989 Jan; 113(1):50-7. PubMed ID: 2909650
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Abnormal red cell metabolism in patients with chronic uremia: Nature of the defect and its persistence despite adequate hemodialysis.
    Yawata Y; Jacob HS
    Blood; 1975 Feb; 45(2):231-9. PubMed ID: 235337
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The influence of autonomic failure on plasma ANF concentration in uremic patients on chronic hemodialysis.
    Zoccali C; Mallamaci F; Ciccarelli M; Parlongo S; Salnitro F
    Clin Nephrol; 1992 Apr; 37(4):198-203. PubMed ID: 1533821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Magnesium and potassium content in patients with heart failure and in healthy persons. Determination in lymphocytes, erythrocytes and plasma].
    Schwinger RH; Antoni DH
    Z Kardiol; 1990 Nov; 79(11):735-41. PubMed ID: 2278165
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of erythropoietin in the reversal of anemia of renal failure with continuous ambulatory peritoneal dialysis.
    Chandra M; McVicar M; Clemons G; Mossey RT; Wilkes BM
    Nephron; 1987; 46(3):312-5. PubMed ID: 3627325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma inhibitors of the erythrocyte hexose monophosphate shunt in uraemia.
    Zingraff J; Kamoun P; Lebreton P; Drüeke T; Man NK; Jungers P
    Proc Eur Dial Transplant Assoc; 1979; 16():475-80. PubMed ID: 548990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute effects of hemodialysis on removal of intracellular solutes.
    Nolph KD; Bass OE; Maher JF
    Trans Am Soc Artif Intern Organs; 1974; 20 B():622-7. PubMed ID: 4476100
    [No Abstract]   [Full Text] [Related]  

  • 49. Mechanism of alteration of sodium potassium pump of erythrocytes from patients with chronic renal failure.
    Cheng JT; Kahn T; Kaji DM
    J Clin Invest; 1984 Nov; 74(5):1811-20. PubMed ID: 6094614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Metabolism of potassium and its flux in erythrocytes].
    Ozawa Y; Yoshida H
    Rinsho Byori; 1999 Dec; 47(12):1134-9. PubMed ID: 10639823
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of uraemia-induced decrease in insulin binding on erythrocytes.
    Marttinen A; Pasternack A; Koivula T
    Nephrol Dial Transplant; 1987; 2(4):233-7. PubMed ID: 3118263
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sodium and potassium concentrations of red blood cells and plasma in children with nephrotic syndrome, uraemia and pyelonephritis.
    Toldi Z; Turi S
    Acta Paediatr Hung; 1986; 27(4):283-8. PubMed ID: 3593578
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Iron absorption in patients with chronic uremia undergoing regular hemodialysis.
    Milman N; Larsen L
    Acta Med Scand; 1976; 199(1-2):113-9. PubMed ID: 1251763
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The red cell sodium, potassium, inorganic phosphate, ATP and 2,3DPG concentrations in chronic renal failure.
    Jabłońska-Skwiecinśka E; Staniszewska K; Kowalska H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(4):493-5. PubMed ID: 2446986
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Red blood cell sodium transport and phosphate release in uremia.
    Walter U; Becht E
    Nephron; 1983; 34(1):35-41. PubMed ID: 6304546
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hemolysis and blood loss in children with chronic renal failure.
    Müller-Wiefel DE; Sinn H; Gilli G; Schärer K
    Clin Nephrol; 1977 Nov; 8(5):481-6. PubMed ID: 589879
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon.
    Sherwin RS; Bastl C; Finkelstein FO; Fisher M; Black H; Hendler R; Felig P
    J Clin Invest; 1976 Mar; 57(3):722-31. PubMed ID: 1249205
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disorders of red blood cell production in uremia.
    Eschbach JW; Adamson JW; Cook JD
    Arch Intern Med; 1970 Nov; 126(5):812-5. PubMed ID: 5475703
    [No Abstract]   [Full Text] [Related]  

  • 59. Whole blood-, plasma- and red blood cell glutathione and cysteine in patients with kidney disease and during hemodialysis.
    Jacobson SH; Moldéus P
    Clin Nephrol; 1994 Sep; 42(3):189-92. PubMed ID: 7994938
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of L-carnitine administration on erythrocyte survival in haemodialysis patients.
    Arduini A; Bonomini M; Clutterbuck EJ; Laffan MA; Pusey CD
    Nephrol Dial Transplant; 2006 Sep; 21(9):2671-2. PubMed ID: 16611680
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.